2
Orphan Designations
0
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Mallory-Weiss syndrome | allogeneic human placental hematopoietic stem cell derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP) | Orphan Designation | - |
| gastric mantle cell lymphoma | allogeneic human placental hematopoietic stem cell derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP) | Orphan Designation | - |
| gastroesophageal reflux disease | allogeneic human placental hematopoietic stem cell derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP) | Orphan Designation | - |
| malignant glioma | taniraleucel | Orphan Designation | - |